CML stem cells and their interactions and adaptations to tyrosine kinase inhibitors. Gullaksen SE, Omsland M, Brevik M, Letzner J, et al. Leuk Lymphoma 2025;66:1211-1220.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gullaksen SE, Omsland M, Brevik M, Letzner J, et al. CML stem cells and their interactions and adaptations to tyrosine kinase inhibitors. Leuk Lymphoma 2025;66:1211-1220.
PMID: 40598814